Latest Guaifenesin Stories

2014-05-08 08:33:14

IRVING, Texas, May 8, 2014 /PRNewswire-USNewswire/ -- Glyceryl guaiacolate ether (GGE) is unlikely to make it easier to cough up phlegm when delivered in the recommended dose. GGE is approved by the FDA as an over-the-counter expectorant and is the active ingredient in Mucinex extended-release and many other cold remedies on the market. The study was published in the May 2014 issue of RESPIRATORY CARE, a journal of the American Association for Respiratory Care. A total of 295 subjects...

2011-07-07 15:37:00

PARSIPPANY, N.J., July 7, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that the United States Court of Appeals for the Federal Circuit has affirmed the United States District Court for the Southern District of Florida's February 2011 decision that Watson's generic versions of Mucinex(R) (Guaifenesin), Mucinex(R) D (Pseudoephedrine/Guaifenesin), and Mucinex(R) DM (Dextromethorphan HBr/ Guaifenesin) Extended-Release products do not infringe U.S. Patent No....

2011-02-09 16:22:00

MORRISTOWN, N.J., Feb. 9, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S....

2011-01-15 00:00:40

Government Partially Intervenes and Whistleblower Moves Forward with Civil Prosecution of 23 Drug Companies for Selling Unapproved Drugs Fort Lauderdale, FL (Vocus/PRWEB) January 13, 2011 The national whistleblower law firm of Nolan & Auerbach, P.A. announces today the unsealing of a whistleblower case filed nearly a decade ago on behalf of its client Constance Conrad. Until today, the public has been unaware that dozens of small and mid-sized pharmaceutical companies have sidestepped...

2010-02-12 07:00:00

ALLEGAN, Mich., Feb. 12 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court...

Word of the Day
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.